May 2002.
Methods | Randomised controlled trial (6 months follow‐up) | |
Participants | 242 patients from 22 epilepsy centres in Germany, Switzerland and Austria Mean age of participants was 38 years; 43% were male |
|
Interventions | Intervention: Modular Service Package Epilepsy (MOSES), a 2‐day educational programme Control: waiting list control |
|
Outcomes |
|
|
Funding | Sanofi‐Synthelabo provided financial support | |
Notes | — | |
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Unclear risk | No details of randomisation provided |
Allocation concealment (selection bias) | Unclear risk | No details of allocation provided. Participants in the control group had a longer duration of epilepsy than those in the intervention group (median 18.2 vs 13.5 years) |
Blinding (performance bias and detection bias) All outcomes | High risk | Authors do not report if any of the participants, clinicians or assessors were blinded. The subjective nature of the outcomes measured (all by self reported questionnaire) means this may have introduced bias |
Incomplete outcome data (attrition bias) All outcomes | High risk | Only 63% of those randomised completed the programme |
Selective reporting (reporting bias) | Low risk | All outcomes detailed in the methods were reported in the results |
Other bias | Unclear risk | No details of power calculations or required sample size were reported |
Overall risk of bias | Unclear risk | Lack of detail about randomisation and allocation (but groups relatively similar at baseline apart from duration of epilepsy); no apparent blinding and a large minority of participants dropped out of the study |